Category: Disease States

Disease States

Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.

A large international study found that a simpler blood test method using plasma P-tau217 can accurately detect Alzheimer’s disease.

Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.

Quest Diagnostics has introduced a self-collection option for HPV screening, improving access to cervical cancer prevention.

A new self-testing microchip for HIV detection aims to provide an affordable, rapid, and accessible way to detect early HIV infections.

A Brazilian study used metabolomic analysis to identify metabolic alterations associated with different severities of preeclampsia.

A machine learning algorithm achieved 97% accuracy in diagnosing celiac disease from biopsy images, potentially improving diagnostic speed.

Researchers have successfully adapted high-field NMR-based lipoprotein analysis to cost-effective benchtop NMR systems.

Labcorp has launched a nationwide blood-based biomarker test, the pTau-217/Beta Amyloid 42 Ratio, to aid in diagnosing Alzheimer’s disease.

A study highlights that premature menopause significantly increases the risk of Type 2 diabetes, emphasizing the need for early detection.

A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.